Pictet Asset Management Holding Sa Cure Vac N.V. Transaction History
Pictet Asset Management Holding Sa
- $98.2 Billion
- Q3 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Cure Vac N.V. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 101,918 shares of CVAC stock, worth $538,127. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101,918
Previous 95,362
6.87%
Holding current value
$538,127
Previous $517,000
6.19%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CVAC
# of Institutions
108Shares Held
22.5MCall Options Held
124KPut Options Held
77.1K-
Glazer Capital, LLC New York, NY4.55MShares$24 Million0.82% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.3MShares$12.1 Million0.78% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$11.9 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X01.71MShares$9.04 Million0.01% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.28 Million10.6% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $990M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...